SCR-LIP-000573 · Claim · machine-readable JSON →

In this review, lipedema patients show a metabolic paradox (frequent BMI ≥30 but preserved insulin sensitivity, normal blood pressure, no hepatic steatosis, normal adiponectin/leptin/CRP) and a LOWER incidence of type 2 diabetes compared with BMI-matched female controls, attributed to a 'protective' effect of gluteofemoral subcutaneous fat deposition.

This single-paper claim was consolidated into general propositions (R-CLM-19); its evidence now sits under:

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
very low (GRADE)
Evidence
1 source(s)
Dates
2026-11-17 → 2026-11-17

Structured evidence, machine-compiled — not a verdict.

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-11-17

Evidence over time

2025Lipedema: A Disease Triggered by M2 Polarized Macrophages? (2025) · consistent

Evidence (1)

Context (PECO)

Populationwomen with lipedema (stages 1-3) vs BMI-matched female controls
Conditionlipedema
Exposuregluteofemoral/peripheral subcutaneous adipose deposition (lipedema)
Comparatorconventional obesity / BMI-matched controls
Outcometype 2 diabetes incidence; metabolic profile (insulin sensitivity, adipokines, CRP, hepatic steatosis)
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Auto-ingested single source; not yet human-reviewed.

Change log